The Rotterdam Eye Hospital, Rotterdam, the Netherlands.
Rotterdam Ophthalmic Institute, Rotterdam, the Netherlands.
Retina. 2020 Sep;40(9):1812-1828. doi: 10.1097/IAE.0000000000002681.
To study the disease course of RPE65-associated inherited retinal degenerations (IRDs) as a function of the genotype, define a critical age for blindness, and identify potential modifiers.
Forty-five patients with IRD from 33 families with biallelic RPE65 mutations, 28 stemming from a genetic isolate. We collected retrospective data from medical charts. Coexisting variants in 108 IRD-associated genes were identified with Molecular Inversion Probe analysis.
Most patients were diagnosed within the first years of life. Daytime visual function ranged from near-normal to blindness in the first four decades and met WHO criteria for blindness for visual acuity and visual field in the fifth decade. p.(Thr368His) was the most common variant (54%). Intrafamilial variability and interfamilial variability in disease severity and progression were observed. Molecular Inversion Probe analysis confirmed all RPE65 variants and identified one additional variant in LRAT and one in EYS in two separate patients.
All patients with RPE65-associated IRDs developed symptoms within the first year of life. Visual function in childhood and adolescence varied but deteriorated inevitably toward blindness after age 40. In this study, genotype was not predictive of clinical course. The variance in severity of disease could not be explained by double hits in other IRD genes.
研究 RPE65 相关遗传性视网膜变性 (IRDs) 的疾病进程作为基因型的函数,定义失明的关键年龄,并确定潜在的修饰因子。
33 个具有双等位基因 RPE65 突变的 IRD 家族的 45 名患者,其中 28 名来自遗传隔离区。我们从病历中收集回顾性数据。用分子反转探针分析鉴定 108 个与 IRD 相关基因中的共存变异。
大多数患者在生命的头几年被诊断出来。白天视力在头四十年内从接近正常到失明不等,并且在第五十年符合世界卫生组织对视力和视野的失明标准。p.(Thr368His)是最常见的变异(54%)。在疾病的严重程度和进展方面观察到了家族内和家族间的可变性。分子反转探针分析证实了所有的 RPE65 变异,并在两名单独的患者中鉴定出 LRAT 中的一个额外变异和 EYS 中的一个变异。
所有 RPE65 相关的 IRD 患者在生命的第一年都出现了症状。儿童和青少年时期的视力功能不同,但在 40 岁后不可避免地恶化到失明。在这项研究中,基因型不能预测临床病程。疾病严重程度的差异不能用其他 IRD 基因的双重打击来解释。